{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:35:41Z","timestamp":1790688941514,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS092497"],"award-info":[{"award-number":["R01NS092497"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005440","name":"U.S. Department of Health & Human Services | NIH | Center for Scientific Review","doi-asserted-by":"publisher","award":["R01AG025952"],"award-info":[{"award-number":["R01AG025952"]}],"id":[{"id":"10.13039\/100005440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>BACE1 is the first enzyme involved in APP processing, thus it is a strong therapeutic target candidate for Alzheimer\u2019s disease. The observation of deleterious phenotypes in BACE1 Knock-out (KO) mouse models (germline and conditional) raised some concerns on the safety and tolerability of BACE1 inhibition. Here, we have employed a tamoxifen inducible BACE1 conditional Knock-out (cKO) mouse model to achieve a controlled partial depletion of BACE1 in adult mice. Biochemical and behavioural characterization was performed at two time points: 4\u20135 months (young mice) and 12\u201313 months (aged mice). A ~50% to ~70% BACE1 protein reduction in hippocampus and cortex, respectively, induced a significant reduction of BACE1 substrates processing and decrease of A\u03b2x-40 levels at both ages. Hippocampal axonal guidance and peripheral nerve myelination were not affected. Aged mice displayed a CA1 long-term potentiation (LTP) deficit that was not associated with memory impairment. Our findings indicate that numerous phenotypes observed in germline BACE1 KO reflect a fundamental role of BACE1 during development while other phenotypes, observed in adult cKO, may be absent when partially rather than completely deleting BACE1. However, we demonstrated that partial depletion of BACE1 still induces CA1 LTP impairment, supporting a role of BACE1 in synaptic plasticity in adulthood.<\/jats:p>","DOI":"10.1038\/s41598-019-56329-7","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T11:03:12Z","timestamp":1577444592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["BACE1 partial deletion induces synaptic plasticity deficit in adult mice"],"prefix":"10.1038","volume":"9","author":[{"given":"Sylvia","family":"Lombardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Chiacchiaretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Tarr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WonHee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Griffin","family":"Sigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Rosahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"Haydon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4842-4529","authenticated-orcid":false,"given":"Matthew E.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Tesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,27]]},"reference":[{"key":"56329_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1126\/science.290.5489.150","volume":"290","author":"L Hong","year":"2000","unstructured":"Hong, L. et al. Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science 290, 150\u2013153 (2000).","journal-title":"Science"},{"key":"56329_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/mcne.1999.0811","volume":"14","author":"I Hussain","year":"1999","unstructured":"Hussain, I. et al. Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci 14, 419\u2013427, https:\/\/doi.org\/10.1006\/mcne.1999.0811 (1999).","journal-title":"Mol Cell Neurosci"},{"key":"56329_CR3","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1073\/pnas.97.4.1456","volume":"97","author":"X Lin","year":"2000","unstructured":"Lin, X. et al. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc Natl Acad Sci USA 97, 1456\u20131460 (2000).","journal-title":"Proc Natl Acad Sci USA"},{"key":"56329_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/990114","volume":"402","author":"S Sinha","year":"1999","unstructured":"Sinha, S. et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402, 537\u2013540, https:\/\/doi.org\/10.1038\/990114 (1999).","journal-title":"Nature"},{"key":"56329_CR5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar, R. et al. Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735\u2013741 (1999).","journal-title":"Science"},{"key":"56329_CR6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/990107","volume":"402","author":"R Yan","year":"1999","unstructured":"Yan, R. et al. Membrane-anchored aspartyl protease with Alzheimer\u2019s disease beta-secretase activity. Nature 402, 533\u2013537, https:\/\/doi.org\/10.1038\/990107 (1999).","journal-title":"Nature"},{"key":"56329_CR7","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.bmcl.2018.12.049","volume":"29","author":"CC Hsiao","year":"2019","unstructured":"Hsiao, C. C., Rombouts, F. & Gijsen, H. J. M. New evolutions in the BACE1 inhibitor field from 2014 to 2018. Bioorg Med Chem Lett 29, 761\u2013777, https:\/\/doi.org\/10.1016\/j.bmcl.2018.12.049 (2019).","journal-title":"Bioorg Med Chem Lett"},{"key":"56329_CR8","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.biopsych.2018.04.022","volume":"84","author":"K Zhu","year":"2018","unstructured":"Zhu, K., Peters, F., Filser, S. & Herms, J. Consequences of Pharmacological BACE Inhibition on Synaptic Structure and Function. Biol Psychiatry 84, 478\u2013487, https:\/\/doi.org\/10.1016\/j.biopsych.2018.04.022 (2018).","journal-title":"Biol Psychiatry"},{"key":"56329_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1474-4422(13)70276-X","volume":"13","author":"R Yan","year":"2014","unstructured":"Yan, R. & Vassar, R. Targeting the beta secretase BACE1 for Alzheimer\u2019s disease therapy. Lancet Neurol 13, 319\u2013329, https:\/\/doi.org\/10.1016\/S1474-4422(13)70276-X (2014).","journal-title":"Lancet Neurol"},{"key":"56329_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s40263-019-00613-7","volume":"33","author":"B Das","year":"2019","unstructured":"Das, B. & Yan, R. A Close Look at BACE1 Inhibitors for Alzheimer\u2019s Disease Treatment. CNS Drugs 33, 251\u2013263, https:\/\/doi.org\/10.1007\/s40263-019-00613-7 (2019).","journal-title":"CNS Drugs"},{"key":"56329_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1750-1326-6-88","volume":"6","author":"TW Rajapaksha","year":"2011","unstructured":"Rajapaksha, T. W., Eimer, W. A., Bozza, T. C. & Vassar, R. The Alzheimer\u2019s beta-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb. Mol Neurodegener 6, 88, https:\/\/doi.org\/10.1186\/1750-1326-6-88 (2011).","journal-title":"Mol Neurodegener"},{"key":"56329_CR12","doi-asserted-by":"publisher","first-page":"38408","DOI":"10.1074\/jbc.M112.415505","volume":"287","author":"B Hitt","year":"2012","unstructured":"Hitt, B. et al. beta-Site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1)-deficient mice exhibit a close homolog of L1 (CHL1) loss-of-function phenotype involving axon guidance defects. J Biol Chem 287, 38408\u201338425, https:\/\/doi.org\/10.1074\/jbc.M112.415505 (2012).","journal-title":"J Biol Chem"},{"key":"56329_CR13","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1126\/science.1132341","volume":"314","author":"M Willem","year":"2006","unstructured":"Willem, M. et al. Control of peripheral nerve myelination by the beta-secretase BACE1. Science 314, 664\u2013666, https:\/\/doi.org\/10.1126\/science.1132341 (2006).","journal-title":"Science"},{"key":"56329_CR14","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/nn1797","volume":"9","author":"X Hu","year":"2006","unstructured":"Hu, X. et al. Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci 9, 1520\u20131525, https:\/\/doi.org\/10.1038\/nn1797 (2006).","journal-title":"Nat Neurosci"},{"key":"56329_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.celrep.2013.06.005","volume":"4","author":"X Hu","year":"2013","unstructured":"Hu, X., He, W., Luo, X., Tsubota, K. E. & Yan, R. BACE1 regulates hippocampal astrogenesis via the Jagged1-Notch pathway. Cell Rep 4, 40\u201349, https:\/\/doi.org\/10.1016\/j.celrep.2013.06.005 (2013).","journal-title":"Cell Rep"},{"key":"56329_CR16","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.1073\/pnas.0710373105","volume":"105","author":"AV Savonenko","year":"2008","unstructured":"Savonenko, A. V. et al. Alteration of BACE1-dependent NRG1\/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice. Proc Natl Acad Sci USA 105, 5585\u20135590, https:\/\/doi.org\/10.1073\/pnas.0710373105 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"56329_CR17","doi-asserted-by":"publisher","first-page":"11693","DOI":"10.1523\/JNEUROSCI.2766-05.2005","volume":"25","author":"FM Laird","year":"2005","unstructured":"Laird, F. M. et al. BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J Neurosci 25, 11693\u201311709, https:\/\/doi.org\/10.1523\/JNEUROSCI.2766-05.2005 (2005).","journal-title":"J Neurosci"},{"key":"56329_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0896-6273(03)00810-9","volume":"41","author":"M Ohno","year":"2004","unstructured":"Ohno, M. et al. BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer\u2019s disease. Neuron 41, 27\u201333 (2004).","journal-title":"Neuron"},{"issue":"459","key":"56329_CR19","doi-asserted-by":"publisher","first-page":"eaao5620","DOI":"10.1126\/scitranslmed.aao5620","volume":"10","author":"Ming-Hsuan Ou-Yang","year":"2018","unstructured":"Ou-Yang, M. H. et al. Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice. Sci Transl Med, 10, https:\/\/doi.org\/10.1126\/scitranslmed.aao5620 (2018).","journal-title":"Science Translational Medicine"},{"key":"56329_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1084\/jem.20171831","volume":"215","author":"X Hu","year":"2018","unstructured":"Hu, X., Das, B., Hou, H., He, W. & Yan, R. BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions. J Exp Med 215, 927\u2013940, https:\/\/doi.org\/10.1084\/jem.20171831 (2018).","journal-title":"J Exp Med"},{"key":"56329_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05541","volume":"445","author":"A Ventura","year":"2007","unstructured":"Ventura, A. et al. Restoration of p53 function leads to tumour regression in vivo. Nature 445, 661\u2013665, https:\/\/doi.org\/10.1038\/nature05541 (2007).","journal-title":"Nature"},{"key":"56329_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13195-014-0089-7","volume":"6","author":"R Vassar","year":"2014","unstructured":"Vassar, R. BACE1 inhibitor drugs in clinical trials for Alzheimer\u2019s disease. Alzheimers Res Ther 6, 89, https:\/\/doi.org\/10.1186\/s13195-014-0089-7 (2014).","journal-title":"Alzheimers Res Ther"},{"key":"56329_CR23","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1038\/emboj.2012.173","volume":"31","author":"PH Kuhn","year":"2012","unstructured":"Kuhn, P. H. et al. Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons. EMBO J 31, 3157\u20133168, https:\/\/doi.org\/10.1038\/emboj.2012.173 (2012).","journal-title":"EMBO J"},{"key":"56329_CR24","doi-asserted-by":"publisher","first-page":"7967","DOI":"10.1128\/MCB.22.22.7967-7981.2002","volume":"22","author":"M Montag-Sallaz","year":"2002","unstructured":"Montag-Sallaz, M., Schachner, M. & Montag, D. Misguided axonal projections, neural cell adhesion molecule 180 mRNA upregulation, and altered behavior in mice deficient for the close homolog of L1. Mol Cell Biol 22, 7967\u20137981 (2002).","journal-title":"Mol Cell Biol"},{"key":"56329_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13024-016-0134-z","volume":"11","author":"M Pigoni","year":"2016","unstructured":"Pigoni, M. et al. Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons. Mol Neurodegener 11, 67, https:\/\/doi.org\/10.1186\/s13024-016-0134-z (2016).","journal-title":"Mol Neurodegener"},{"key":"56329_CR26","doi-asserted-by":"publisher","first-page":"8677","DOI":"10.1523\/JNEUROSCI.2440-08.2008","volume":"28","author":"H Wang","year":"2008","unstructured":"Wang, H., Song, L., Laird, F., Wong, P. C. & Lee, H. K. BACE1 knock-outs display deficits in activity-dependent potentiation of synaptic transmission at mossy fiber to CA3 synapses in the hippocampus. J Neurosci 28, 8677\u20138681, https:\/\/doi.org\/10.1523\/JNEUROSCI.2440-08.2008 (2008).","journal-title":"J Neurosci"},{"key":"56329_CR27","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.biopsych.2014.10.013","volume":"77","author":"S Filser","year":"2015","unstructured":"Filser, S. et al. Pharmacological inhibition of BACE1 impairs synaptic plasticity and cognitive functions. Biol Psychiatry 77, 729\u2013739, https:\/\/doi.org\/10.1016\/j.biopsych.2014.10.013 (2015).","journal-title":"Biol Psychiatry"},{"key":"56329_CR28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.nbd.2006.12.008","volume":"26","author":"M Ohno","year":"2007","unstructured":"Ohno, M. et al. BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP\/PS1 transgenic mice. Neurobiol Dis 26, 134\u2013145, https:\/\/doi.org\/10.1016\/j.nbd.2006.12.008 (2007).","journal-title":"Neurobiol Dis"},{"key":"56329_CR29","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","volume":"378","author":"MF Egan","year":"2018","unstructured":"Egan, M. F. et al. Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer\u2019s Disease. N Engl J Med 378, 1691\u20131703, https:\/\/doi.org\/10.1056\/NEJMoa1706441 (2018).","journal-title":"N Engl J Med"},{"key":"56329_CR30","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","volume":"380","author":"MF Egan","year":"2019","unstructured":"Egan, M. F. et al. Randomized Trial of Verubecestat for Prodromal Alzheimer\u2019s Disease. N Engl J Med 380, 1408\u20131420, https:\/\/doi.org\/10.1056\/NEJMoa1812840 (2019).","journal-title":"N Engl J Med"},{"key":"56329_CR31","doi-asserted-by":"publisher","first-page":"363ra150","DOI":"10.1126\/scitranslmed.aad9704","volume":"8","author":"ME Kennedy","year":"2016","unstructured":"Kennedy, M. E. et al. The BACE1 inhibitor verubecestat (MK-8931) reduces CNS beta-amyloid in animal models and in Alzheimer\u2019s disease patients. Sci Transl Med 8, 363ra150, https:\/\/doi.org\/10.1126\/scitranslmed.aad9704 (2016).","journal-title":"Sci Transl Med"},{"key":"56329_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/dvg.22352","volume":"51","author":"D Ripoche","year":"2013","unstructured":"Ripoche, D. et al. Generation of a conditional mouse model to target Acvr1b disruption in adult tissues. Genesis 51, 120\u2013127, https:\/\/doi.org\/10.1002\/dvg.22352 (2013).","journal-title":"Genesis"},{"key":"56329_CR33","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1111\/j.1471-4159.2006.04178.x","volume":"99","author":"K Nishitomi","year":"2006","unstructured":"Nishitomi, K. et al. BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice. J Neurochem 99, 1555\u20131563, https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04178.x (2006).","journal-title":"J Neurochem"},{"key":"56329_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fnmol.2016.00159","volume":"9","author":"C Becker-Pauly","year":"2016","unstructured":"Becker-Pauly, C. & Pietrzik, C. U. The Metalloprotease Meprin beta Is an Alternative beta-Secretase of APP. Front Mol Neurosci 9, 159, https:\/\/doi.org\/10.3389\/fnmol.2016.00159 (2016).","journal-title":"Front Mol Neurosci"},{"key":"56329_CR35","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1096\/fj.08-106666","volume":"22","author":"X Hu","year":"2008","unstructured":"Hu, X. et al. Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves. FASEB J 22, 2970\u20132980, https:\/\/doi.org\/10.1096\/fj.08-106666 (2008).","journal-title":"FASEB J"},{"key":"56329_CR36","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.4103\/1673-5374.217319","volume":"12","author":"C Tallon","year":"2017","unstructured":"Tallon, C. & Farah, M. H. Beta secretase activity in peripheral nerve regeneration. Neural Regen Res 12, 1565\u20131574, https:\/\/doi.org\/10.4103\/1673-5374.217319 (2017).","journal-title":"Neural Regen Res"},{"key":"56329_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fnagi.2018.00229","volume":"10","author":"T Blume","year":"2018","unstructured":"Blume, T. et al. BACE1 Inhibitor MK-8931 Alters Formation but Not Stability of Dendritic Spines. Front Aging Neurosci 10, 229, https:\/\/doi.org\/10.3389\/fnagi.2018.00229 (2018).","journal-title":"Front Aging Neurosci"},{"key":"56329_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00401-013-1152-3","volume":"126","author":"PC Kandalepas","year":"2013","unstructured":"Kandalepas, P. C. et al. The Alzheimer\u2019s beta-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques. Acta Neuropathol 126, 329\u2013352, https:\/\/doi.org\/10.1007\/s00401-013-1152-3 (2013).","journal-title":"Acta Neuropathol"},{"key":"56329_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nn.4188","volume":"19","author":"U Das","year":"2016","unstructured":"Das, U. et al. Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway. Nat Neurosci 19, 55\u201364, https:\/\/doi.org\/10.1038\/nn.4188 (2016).","journal-title":"Nat Neurosci"},{"key":"56329_CR40","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.neuron.2007.09.018","volume":"56","author":"JM Gunnersen","year":"2007","unstructured":"Gunnersen, J. M. et al. Sez-6 proteins affect dendritic arborization patterns and excitability of cortical pyramidal neurons. Neuron 56, 621\u2013639, https:\/\/doi.org\/10.1016\/j.neuron.2007.09.018 (2007).","journal-title":"Neuron"},{"key":"56329_CR41","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.celrep.2015.07.059","volume":"12","author":"S Barao","year":"2015","unstructured":"Barao, S. et al. Antagonistic Effects of BACE1 and APH1B-gamma-Secretase Control Axonal Guidance by Regulating Growth Cone Collapse. Cell Rep 12, 1367\u20131376, https:\/\/doi.org\/10.1016\/j.celrep.2015.07.059 (2015).","journal-title":"Cell Rep"},{"key":"56329_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson, T. et al. A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature 488, 96\u201399, https:\/\/doi.org\/10.1038\/nature11283 (2012).","journal-title":"Nature"},{"key":"56329_CR43","doi-asserted-by":"publisher","first-page":"30990","DOI":"10.1074\/jbc.M114.589069","volume":"289","author":"JA Maloney","year":"2014","unstructured":"Maloney, J. A. et al. Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein. J Biol Chem 289, 30990\u201331000, https:\/\/doi.org\/10.1074\/jbc.M114.589069 (2014).","journal-title":"J Biol Chem"},{"key":"56329_CR44","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/ana.24969","volume":"82","author":"H Martiskainen","year":"2017","unstructured":"Martiskainen, H. et al. Decreased plasma beta-amyloid in the Alzheimer\u2019s disease APP A673T variant carriers. Ann Neurol 82, 128\u2013132, https:\/\/doi.org\/10.1002\/ana.24969 (2017).","journal-title":"Ann Neurol"},{"key":"56329_CR45","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1056\/NEJMc1813435","volume":"380","author":"D Henley","year":"2019","unstructured":"Henley, D. et al. Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer\u2019s Disease. N Engl J Med 380, 1483\u20131485, https:\/\/doi.org\/10.1056\/NEJMc1813435 (2019).","journal-title":"N Engl J Med"},{"key":"56329_CR46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-018-0239-7","volume":"13","author":"W Kim","year":"2018","unstructured":"Kim, W. et al. BACE1 elevation engendered by GGA3 deletion increases beta-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice. Mol Neurodegener 13, 6, https:\/\/doi.org\/10.1186\/s13024-018-0239-7 (2018).","journal-title":"Mol Neurodegener"},{"key":"56329_CR47","doi-asserted-by":"publisher","first-page":"17020","DOI":"10.1074\/jbc.M409467200","volume":"280","author":"YW Zhang","year":"2005","unstructured":"Zhang, Y. W. et al. Nicastrin is critical for stability and trafficking but not association of other presenilin\/gamma-secretase components. J Biol Chem 280, 17020\u201317026, https:\/\/doi.org\/10.1074\/jbc.M409467200 (2005).","journal-title":"J Biol Chem"},{"key":"56329_CR48","doi-asserted-by":"publisher","first-page":"20664","DOI":"10.1074\/jbc.M109.055608","volume":"285","author":"S Ullrich","year":"2010","unstructured":"Ullrich, S. et al. The novel membrane protein TMEM59 modulates complex glycosylation, cell surface expression, and secretion of the amyloid precursor protein. J Biol Chem 285, 20664\u201320674, https:\/\/doi.org\/10.1074\/jbc.M109.055608 (2010).","journal-title":"J Biol Chem"},{"key":"56329_CR49","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nature methods 9, 676\u2013682, https:\/\/doi.org\/10.1038\/nmeth.2019 (2012).","journal-title":"Nature methods"},{"key":"56329_CR50","doi-asserted-by":"publisher","unstructured":"Papouin, T. & Haydon, P. G. Obtaining Acute Brain Slices. Bio Protoc, 8, https:\/\/doi.org\/10.21769\/BioProtoc.2699 (2018).","DOI":"10.21769\/BioProtoc.2699"},{"key":"56329_CR51","doi-asserted-by":"publisher","first-page":"e0155799","DOI":"10.1371\/journal.pone.0155799","volume":"11","author":"KR Walker","year":"2016","unstructured":"Walker, K. R. et al. Genetic Deletion of the Clathrin Adaptor GGA3 Reduces Anxiety and Alters GABAergic Transmission. PLoS One 11, e0155799, https:\/\/doi.org\/10.1371\/journal.pone.0155799 (2016).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56329-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56329-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56329-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T18:00:22Z","timestamp":1671300022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56329-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,27]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["56329"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-56329-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,27]]},"assertion":[{"value":"28 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.L., M.C., A.T., W.K., T.C., G.S., W.X., P.G.H. and G.T. report no biomedical financial interests or potential conflicts of interest. M.E.K. and T.W.R. are full time employees of Merck &Co. Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19877"}}